Fundz
Free weekly newsletter

Get the free weekly contract digest

The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New new contracts, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Contract Trends

See who's moving and how much in your market

No credit card required Weekly contract digest

Novartis partners with Ratio Therapeutics for $745M radiopharma development

Nov 18, 2024•over 1 year ago

Contract Type

partnership

SwitzerlandBiotechnologyHealth Carepharmaceuticals

Description

Novartis has secured a partnership with radiopharmaceutical biotech Ratio Therapeutics to collaborate on the development of a cancer candidate. The partnership will utilize Ratio’s radioligand therapy discovery and development expertise to research a somatostatin receptor 2 (SSTR2) radiotherapeutic drug.

Company Information

Company

Novartis

Location

2 Fabrikstrasse

Switzerland

About

Novartis is a global healthcare company based in Switzerland. It is focused on developing innovative medicines to improve and extend people's lives. The company operates in various therapeutic areas, including oncology, cardiology, and immunology. Novartis is known for its commitment to research and development.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Novartis's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.